Presentation is loading. Please wait.

Presentation is loading. Please wait.

National Deanery in Pharmaceutical Medicine Specialty Training Update

Similar presentations


Presentation on theme: "National Deanery in Pharmaceutical Medicine Specialty Training Update"— Presentation transcript:

1 National Deanery in Pharmaceutical Medicine Specialty Training Update
3rd National Trainees Meeting Alan Boyd Chair, SAC – Pharmaceutical Medicine May 2011 NATIONAL DEANERY OF PHARMACEUTICAL MEDICINE FACULTY OF PHARMACEUTICAL MEDICINE of the Royal Colleges of Physicians of the United Kingdom

2 Introduction: Pharmaceutical Medicine Specialty Training:
Higher Medical Training commenced in UK on 1 April 2003 following the recognition & listing of the medical Specialty of Pharmaceutical Medicine on 22 April 2002 PMST (PMST1) superseded HMT on 1 August 2007 PMST2 (curriculum 2010) superseded PMST1 on 1st August formal introduction of workplace based assessments (WPBAs) and the introduction of the e-Portfolio to replace the paper-based Training Record.

3 Current Status - Trainees
148 Pharmaceutical Physicians now hold a CCT in Pharmaceutical Medicine 213 Trainees now hold an NTN 196 via the CCT route 17 via the Combined CESR route HMT PMST PMST Local Educational Providers: 66 Sites 31 LEPs have more than 1 Trainee Top-Ten have between 5-25 35 have 1 Trainee 7 Trainees working outside the UK in approved LEPs

4 In total, 392 doctors have enrolled in HMT/PMST since 2003
Current Status - Trainees 43 Trainees have resigned from the programme since 2005 – moved out of UK, left Pharmaceutical Medicine or personal reasons Current rate of enrolment is about 25 new Trainees per annum In total, 392 doctors have enrolled in HMT/PMST since 2003

5 Current Status – Specialty League Table
34 Specialties within JRCTB Largest is General Internal Medicine – 3258 Trainees Smallest is Metabolic Medicine – 3 Trainees Pharmaceutical Medicine is the 12th largest Similar size to Acute Medicine, Neurology & Rheumatology Larger than Medical Oncology, Dermatology & Infectious Diseases

6 Governance & Supervision
The National Deanery of Pharmaceutical Medicine Deanery (comprising the Lead Postgraduate Dean and Faculty of Pharmaceutical Medicine), in conjunction with the Joint Royal Colleges of Physicians' Training Board (JRCPTB), is responsible for PMST and reports to the GMC The first and only National Deanery – others currently being modelled on our experiencies All Specialties are governed by the same GMC Regulations

7 Senior Specialty Advisers (SSAs)
31 active SSAs - role is governance and quality management over the PMST programme in training organisations. Each SSA is allocated sites within their geographical reach and have between 1-7 sites each, covering 1-20 trainees for each SSA SSAs also serve on ARCP/RITA Panels to review & evaluate trainees’ progress & achievement on an annual basis. Majority of SSAs are Fellows of Faculty 4 SSAs also hold a CCST/CCT in Pharmaceutical Medicine.

8 46 ESs & SSAs (28%) now hold a CCT in Pharmaceutical Medicine
Educational Supervisors (ESs) There are currently 150 Trained & Approved ESs Over 100 ESs are currently active Supervise 1-2 Trainees each – though a few have 3-5 Supervision estimated to take 1 hour per week ESs can become ‘Accredited Educational Supervisors’ 46 ESs & SSAs (28%) now hold a CCT in Pharmaceutical Medicine

9 Conduct of HMT/PMST Approximately 70% of HMT/PMST takes place
on-the-job in the work place Approximately 30% of HMT/PMST takes place through taught courses Approved External Modular Courses: King’s College London – RGN, CLP, CLD Parexel (Richard Kay) – SDM DSRU, Southampton – DSS New Courses at Kings – HMP & Bath Univ - DSS

10 Diploma in Pharmaceutical Medicine Exam :
YEAR PASS RATE CANDIDATES 2005 70% 43 2006 33% 48 2007 39% 49 2008 40% 55 2009 48% 40 2010 42% 65

11 Diploma in Pharmaceutical Medicine Exam :
Current Situation 213 active Trainees – 48 have passed the DPM 165 Trainees need to sit or re-sit the DPM prior to completing CCT Of the Trainees who commenced in or before 2009 - 122 could or should sit the 2011 exam - 38 Re-sits & 84 First time - All 122 need to pass exam either in 2011,2012 or 2013 Failure to sit or pass the DPM is main reason for RITA E or Outcome 3 46 RITA D or Es/Outcome 2 or 3 issued to date - 41 due to failure to pass DPM within CCT Timeline (Failed or not taken exam)

12 Organisation of the National Deanery
& QM Processes: SAC-PM & National Deanery Senior Specialty Advisers (SSA) Local Educational Providers Companies & Trainers (ES &AES) Trainees GMC

13 Organisation of the National Deanery
& QM Processes: QA of External Courses Trainee Progression – RITA/ARCPs QM Process of the PMST Programme by the National Deanery in Pharmaceutical Medicine Annual Report to GMC Includes Issues and Good Practice – SSA Input Trainee & Trainer Surveys – Trainee & ES Input

14 Annual Deanery Report to GMC - 2010
GMC recently confirmed continuation of approval for the Pharmaceutical Medicine National Deanery Items of Good Practice: Face-to-Face ARCPs & RITAs Review & Evaluation of External Courses against Curriculum Trainees working in Teams – e.g. No single trainee signs off a Clinical Study Protocol Bespoke ‘effective ES Training Programme’ Extensive online E-Learning enables Curriculum delivery – e.g. Roche & GSK Areas for Attention: Information on Formative Assessments for Trainees on Pre-2010 Curriculum Information on Schedule for Visits to LEPs

15 Peer Support Group for PMST
Acknowledgement and thanks should be given to the large support group that HMT/PMST has acquired over the years, including trainees, numbering almost 600 people comprising: SSAs, ESs, AESs, Lead Postgraduate Dean, E&T Committees (SAC-PM; FPM Education Committee; Trainees Subcommittee, Working Groups (especially CAWG)), JRCPTB Administrators, Faculty Education and Standards Administrators, Education Department RCP, Faculty Board of Examiners, Modular Course Providers and course Faculties, Modular Course QM Convenors Group and QM Panellists, Postgraduate courses in Pharmaceutical Medicine & their Faculties, Company Management, Lay Representatives, and of course you the Trainees.

16 CCT in Pharmaceutical Medicine
Summary of 2003 to 2011 Pharmaceutical Medicine Specialty training is now in its 9th Year Nearly 400 Doctors have enrolled into the programme to date Currently there are 213 active Trainees Now 12th Largest Medical Specialty 148 CCTs have been awarded to individuals who are now acknowledged Specialists in Pharmaceutical Medicine

17 3rd National Trainees Meeting
A few Questions from me: The CCT in Pharmaceutical Medicine – Why do you want a CCT in Pharmaceutical Medicine? What do you get out of it? Does your Company/Organisation recognise its importance? What does your Company/Organisation get out of it?

18 QUESTIONS & Thanks !

19 National Deanery of Pharmaceutical Medicine &
Faculty of Pharmaceutical Medicine Of the Royal Colleges of Physicians of the United Kingdom 1 St Andrew’s Place Regent’s Park London NW1 4LB


Download ppt "National Deanery in Pharmaceutical Medicine Specialty Training Update"

Similar presentations


Ads by Google